The BRAF(V600E) mutation analysis and risk stratification in papillary thyroid carcinoma

OBJECTIVE: Although the prognostic role of BRAF(V600E) mutation in papillary thyroid carcinoma (PTC) is controversial, the American Thyroid Association (ATA) includes the mutational status in their risk stratification system. To evaluate the impact of the BRAF(V600E) mutation status on PTC risk stra...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheffel, Rafael Selbach, de Cristo, Ana Patrícia, Romitti, Mirian, Vargas, Carla Vaz Ferreira, Ceolin, Lucieli, Zanella, André B., Dora, Jose Miguel, Maia, Ana Luiza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528629/
https://www.ncbi.nlm.nih.gov/pubmed/34033285
http://dx.doi.org/10.20945/2359-3997000000285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528629/
https://www.ncbi.nlm.nih.gov/pubmed/34033285
http://dx.doi.org/10.20945/2359-3997000000285

Ejemplares similares